Achievement of rapid complete remission in an 87-year-old female patient with azacytidine-venetoclax for blastic plasmacytoid dendritic cell neoplasm.

1 Pre-treatment TEP SCAN (a) and after 3 months of treatment (b) A PET scan was performed after the third cycle of association showing a complete metabolic remission (Fig. 1:CAS:528:DC%2BD1MXmvFyjur0%3D. 10.1111/j.1365-2141.2009.07679.x 2 Garnache-Ottou F, Vidal C, Biichlé S, Renosi F, Poret E, Pagadoy M. How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients? Recent papers [[6]-[8]] showed that venetoclax combined with decitabine or 5-Aza in treatment-naive elderly patients with AML was effective and well tolerated, leading this association to become a standard of treatment in this indication. [Extracted from the article]